Abstract
The substance combination of codeine and promethazine, commonly termed lean/sizzurp, has been identified as a method that some individuals use to cope with PTSD and other mental health symptomology. A sample of 1423 adults with self-reported past year lean use was recruited from substance-related Reddit pages to complete a survey about lean, including information about using lean to cope with emotions, thoughts, or feelings. To be included in the sample, persons needed to: (1) be ⩾18 years old, (2) report past year lean use, (3) complete lean use screeners, and (4) pass data quality checks (eg, bot detection). As Reddit is an online forum, no geographic restrictions were placed on study participation. Data on demographic characteristics, lean use, and mental health disorder symptomology were captured from participants. Logistic regression models included anxiety, depression, and trauma as independent variables along with covariates to examine using lean to cope with emotions, thoughts, or feelings in the past 30 days. Most participants were male (n = 1102; 77.4%), with an average age of 26.9 (SD = 5.2) years. Most participants used included codeine as an ingredient in lean (n = 1060; 74.5%); promethazine was added as an ingredient by 31.7% of the sample (n = 451), and the combination of codeine and promethazine was included as ingredients by 13.5% (n = 192) of the sample. Participants with anxiety, lifetime trauma exposure, and who were female had increased odds of using lean to cope with emotions, thoughts, or feelings in the past 30 days. Those with depression and unstable housing exhibited decreased odds of using lean to cope with emotions, thoughts, or feelings in the past 30 days. This study recruited persons via social media to learn more about lean use, especially lean use to cope with mental health symptoms; future population-level studies are needed.
Keywords: Codeine, lean, mental health, promethazine, PTSD, substance use
Introduction
Lean or sizzurp is a cough syrup liquid mixture of codeine and promethazine (sometimes called barre, purple drank, amongst other names).1 -5 Due to the unpleasant taste, 6 sweeteners such as soda or candy are often added to lean before consumption.2,7,8 Lean is prominent in popular culture, especially music, in which numerous songs have described lean consumption.4,9 -12 Because lean is highly visible in popular culture, the scarce research to date on this substance combination is concerning, particularly given the evidence that some persons could develop a substance use disorder (SUD) from consuming lean.2,4,9,13
Despite the available evidence on lean, which identifies its potential for health consequences,2,4,9,13 there is not much research on the overall prevalence of lean use. 4 Some studies based on the prevalence of lean use in study samples within specific geographic regions exist.1,4,8,9 For example, a study among college students in the southeastern United States found that approximately 6.5% of the sample ever consumed lean.1,8 Another study examining data captured from electronic dance music party attendees in New York City found that 15.5% of the sample ever consumed lean. 9 Data on medical diversion appear to highlight the use of lean. Among a sample of pharmacies in France, codeine and promethazine were reported as the most requested substances that pharmacists suspected of being used for means other than prescribed, especially among young adults. 3 Adolescents and young adults may be at risk of misusing codeine and promethazine2,5 due to social networks, 10 internet usage, and popular culture.3,7,9,13,14 Different groups across genders, ethnic groups, sexual orientations, and racial groups have been shown to consume lean.1,4,9,10,15
Although lean is being used recreationally,9,16,17 there is the potential for side effects, toxicity, health risks, developing a SUD,2,4,13 and overdose.5,9,13,14,18,19 Indeed, potential adverse events from drinking lean include drowsiness, hallucinations, neuropsychological complications, respiratory depression, and even death.2,11,13,14,18,19 One of the substances in lean is codeine, an opioid that places individuals at risk of overdose.13,14
Notably, along with recreational use, lean consumption has been identified both in music 11 and in the academic literature 20 as a method that some individuals use to cope with PTSD and other mental health symptomology. A research correspondence described the importance of examining factors related to lean use, especially lean use associated with coping with trauma or stressors. 20 Although no studies to date have used clinical or survey data to examine individuals specifically using lean to cope with mental health symptoms, other evidence suggests that substances are sometimes used to cope with distress.21,22 Therefore, learning more about individuals using lean to cope with mental health symptomology is critical for effective intervention planning and prevention efforts. Investigating the use of lean overall alongside individuals using it to cope has importance because not much is known about the broader societal impacts, current treatment trends, and treatment gaps.
This cross-sectional exploratory study was conducted to use self-reported survey data to learn more about (1) lean ingredients (to learn more about the proportion of individuals that include codeine, promethazine, or other ingredients in lean), (2) lean use frequency (how often lean was consumed in the past 12 months), (3) lean use disorder screening criteria (completing exploratory screeners that could potentially identify at-risk lean use), and (4) the association between anxiety, depression, and PTSD symptomology with using lean to cope (to learn more about persons using lean to cope with emotions, thoughts, or feelings related to mental health symptoms) among adults who reported lean use in the past 12 months. This study sought to increase the knowledge base on lean by collecting survey data online from adults in substance use and substance-related subReddits (discussed in the Methods section) from October 2022 to January 2023. Findings from this study are needed for clinical 20 and research purposes primarily for treatment interventions.
Methods
Recruitment and procedures
All study procedures were approved by the University of North Carolina at Chapel Hill Institutional Review Board; Principal Investigator [PI]: Ware, Reference ID: 370263. Participants were recruited from Reddit, a highly popular online content and discussion forum. The PI sent messages to 21 moderators (individuals who manage/monitor forums on Reddit) of subReddits (ie, subject-specific forums), 20 of which focused on substances and 1 of which focused on music, to gain permission to post recruitment materials to these subReddits. The specific names of the subReddits are not listed in the current paper to follow the wishes of some of the subReddit moderators. If the moderators did not respond after the first message, they were sent at least one more follow-up message after 10 days. Ten subReddit page moderators did not respond, five declined, two asked for payment from the PI to post recruitment materials (which the PI was unable to accommodate and declined), and four provided approvals to post recruitment materials.
One of the subReddit moderators that provided approval gave access to recruit from 3 other substance-related subReddits not initially contacted by the PI. After receiving moderator approval, recruitment materials were posted to a total of 7 subReddits focused on substances approximately once per week from October 2022 to November 2022 on a rolling basis. Recruitment materials included a flyer with the study’s description, brief eligibility criteria, the IRB study number, the PI’s contact information, a QR code directing individuals to the study survey on Qualtrics, 23 the full link for the survey on Qualtrics, and incentive information (ie, survey completers entering a drawing in which everyone had equal odds of receiving 1 of 20 $50 electronic gift cards). Some subReddits did not allow posts that included images. In these instances, the post would only include the wording from the survey flyers without a QR code. The survey, survey link, and QR code were active until early January 2023. Using features in Qualtrics, 23 responses were anonymized (no location data was collected), and bot detection was activated (reCAPTCHA).
After using the QR code or full link, persons interested in the study were taken to the survey in Qualtrics. The first page included a description of the study (a one-time 20-minute anonymous online survey), the voluntary nature of the survey, IRB contact information, PI contact information, and a prompt asking if individuals were interested in completing the eligibility screening questions. Individuals (1) at least 18 years old, (2) who responded yes to “Have you ever used lean? Sometimes it is called purple, purple drank, double cup, sizzurp, or dirty sprite,” (3) and who responded accurately to a quality check question were eligible to participate. The quality check question was, “I will answer these questions,” with response options “Truthfully” and “Untruthfully.”
Ineligible respondents were notified of their ineligibility and thanked for their time. Eligible respondents were notified of their eligibility and asked if they would like to participate in the study. Eligible respondents who declined were thanked for their time and exited from the webpage, while eligible respondents who elected to participate started the survey. Participants who completed the survey were informed of the next steps regarding the incentive, given a four-digit number, and provided a link for a separate Qualtrics survey to add their e-mail addresses for the incentive drawing. This incentive survey asked participants for the code they were provided in the study survey, their e-mail addresses, and if they were willing to be contacted for future studies. Separating these surveys allowed for study survey responses to be unlinked from e-mail addresses. The electronic gift card incentives were dispensed by e-mail after the data collection period by using a random number generator to select incentive recipients. Individuals selected to receive incentives who did not respond to 3 e-mails from the PI sent over 4 weeks were replaced by another individual who was selected randomly.
Measures
Demographics
Demographic data captured include age, employment status, gender, housing status, race/ethnicity, and sexual identity.
Age
Age was determined by asking respondents, “What is your age in years?” They were then able to select numerical responses that ranged from 18 to 75, or categorical responses, “younger than 18 years old” and “older than 75 years old.” Selecting “younger than 18 years old” was study exclusion criteria as described in the recruitment and procedures section above.
Employment status
Employment status was determined by asking respondents, “What best describes your employment status?” Participants could select one of the following options: (a) disabled or unable to work, (b) employed full-time, (c) employed part-time, (d) unemployed, or (e) student.
Gender
Gender identity was identified by asking respondents, “How do you describe yourself?” Participants could select one of the following options: (a) male/man, (b) female/woman, (c) transgender male/man, (d) transgender female/woman, (e) genderqueer, gender non-conforming, or non-binary, and (f) different identity. During data analysis, some cases were combined into the category of Other gender identity due to small cell sizes.
Housing status
Housing status was determined by respondents answering the following question “What is your housing situation today?” with response options including: (a) I have housing, (b) I have housing today, but I am worried about losing housing in the future, and (c) I do not have housing (I am staying with others, in a hotel, in a shelter, living outside on the street, on a beach, in a car, abandoned building, bus or train station, or in a park). 24
Race/ethnicity
Race/ethnicity was determined by 2 questions. For the first question, which asked, “What best describes your ethnicity?,” respondents could select (1) Hispanic or Latino or (2) Non-Hispanic or Latino. For the second question, which asked, “What best describes your race? (please select all that apply),” respondents could select any of the following responses: (1) American Indian or Alaska Native, (2) Asian, (3) Black or African American, (4) Native Hawaiian or Other Pacific Islander, (5) White, and (6) Other (please describe). During data analysis, race and ethnicity variables were combined. Some responses were combined into a category called Other Race and Ethnicity due to small cell sizes.
Sexual identity
Sexual identity was identified by asking respondents, “Which of these best describes your current sexual orientation?” and to select 1 of the following options: (a) Asexual, (b) Bisexual, (c) Gay or Lesbian, (d) Heterosexual or Straight, (e) Pansexual, and (f) Queer. Some cases were combined into the category of Other Sexual Identity due to small cell sizes.
Hospital anxiety and depression scale
The Hospital Anxiety and Depression Scale (HADS), is a brief standardized 14-item measure used to screen for anxiety and depression symptoms. 25 Seven items focus on anxiety and 7 focus on depression. There are 4 responses per item with values ranging from 0 to 3. Possible scores for the separate anxiety and depression subscales range from 0 to 21, with 2 cutoffs: (1) 0 to 7: Normal and (2) ⩾8: Anxiety or Depression Risk. 25 A sample item for the anxiety subscale is “I feel tense or ‘wound up’” and, for the depression subscale, “I still enjoy the things I used to enjoy.” 25 The HADS was used for this study because it is relatively brief and has been shown to be a reliable and valid measure in other studies.25-30 The Cronbach alpha for the anxiety and depression subscales in this sample were α = .63 and α = .49, respectively. The Cronbach alpha for the full 14-item measure is α = .66.
Primary care PTSD screen
The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5), is a brief standardized 5-item measure with an extra lead-in question used to screen for PTSD. 31 The lean-in question establishes if the respondent has ever experienced a traumatic event (ie, lifetime trauma exposure). If the respondent answers No to the lead-in question, the survey ends. If the respondent answers yes, they complete 5 items with binary response options, Yes (scored as 1) and No (scored as 0). Total scores for this measure range from 0 to 5, with higher scores indicating a higher risk of PTSD. 31 A sample item is, “In the past month, have you had nightmares about the event(s) or thought about the event(s) when you did not want to?” 31 Previous research has identified this measure as an effective diagnostic screener for PTSD among a sample of veterans. 31 The PC-PTSD-5 measure used for this study because it is relatively brief, has been identified as easy to understand, and is effective in accurately identifying individuals at risk of PTSD. 31 The Cronbach alpha for the 5 items in this sample was α = .58.
Lean ingredients
To identify the ingredients in a respondent’s lean mixture, they were asked, “What ingredients are in your lean (please select all that apply)?” Participants could select any of 3 response options: (a) codeine, (b) promethazine, and (c) other ingredients.
Lean to cope
Participants were asked 2 questions: “Have you ever used lean to cope with physical pain?” and “Have you ever used lean to cope with emotions, thoughts, or feelings?” Both items had binary values (yes and no). If respondents answered yes to the item on coping with emotions, thoughts, or feelings, they were asked a follow-up question, “Have you used lean to cope with emotions, thoughts, or feelings in the last 30 days?” This item also had yes and no binary response options.
Lean use disorder identification test
The Lean Use Disorder Identification Test (LUDIT) is a 3-item measure that was adapted from the Alcohol Use Disorders Identification Test-Concise 32 for this study. Items were changed to mention lean instead of alcohol. These items may be found in Supplemental Screener 1. Specific items and response options include: (1) “How often did you drink lean in the past year?” (Never = 0; Monthly or less = 1; 2 to 4 times a month = 2; 2 to3 times per week = 3; 4 or more times a week = 4); (2) “How many drinks containing lean did you have on a typical day in the past year?” (1 or 2 drinks = 0; 3 or 4 drinks = 1; 5 or 6 drinks = 2; 7 to 9 drinks = 3; 10 or more drinks = 4); and (3) “How often did you have 3 or more drinks of lean on 1 occasion in the past year?” (never = 0; less than 1 = 1; monthly = 2; weekly = 3; daily or almost daily = 4). Respondents that answered Never to the first item were not asked the 2 follow-up questions. Possible total scores ranged from 0 to 12 with higher scores indicating a higher risk for lean use disorder. All individuals in this current analysis selected a response other than Never for the first question of the LUDIT. The Cronbach alpha for the 3 items in this sample was α = .55.
Lean use disorder
The Lean Use Disorder (LUD) measure is an 11-item measure that was adapted from the 11 substance use disorder symptoms listed in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revision (DSM-5-TR) 33 for this study. The 11 DSM-5-TR symptoms were asked in relation to their lean use. The items may be found in Supplemental Screener 2. Respondents selected yes (value = 1) or no (value = 0) to experiencing 11 SUD symptoms related to their lean use in the last 12 months, with possible total scores ranging from 0 to 11. The following clinical cutoffs from the DSM-5-TR were used to identify past 12 month LUD: (a) a score of 0 to 1 (no LUD); (b) a score of 2 to 3 (mild LUD); (c) a score of 4 to 5 (moderate LUD); and (d) a score of ⩾6 (severe LUD). 33 A sample item is, “In the last 12 months, have you used lean in large amounts or over longer periods of time than intended?” 33 The Cronbach alpha for this sample is α = .59.
Lean past 30-day use
Respondents were asked the following question, which had binary yes no response options: “Have you used lean in the last 30 days?”
Sample
The dataset downloaded from Qualtrics contained a total of 2883 cases. Exclusionary criteria led to n = 1046 cases being excluded using Qualtrics’ bot detection feature, n = 301 excluded for not meeting the survey eligibility screening, n = 9 eligible persons excluded for not selecting Yes to study participation, and n = 104 excluded for not meeting criteria for the current analyses. The final analytic sample was 1423 individuals (Supplemental Figure 1).
Analysis
Analyses were conducted using IBM SPSS Statistics Version 28.0 34 in a Secure Research Workspace provided by the University of North Carolina at Chapel Hill’s Information Technology Services. Univariate statistics were used to describe the study sample. Bivariable analyses were used to examine associations between variables and measures. Multivariable analyses included logistic regression models. The first binary logistic regression model included “Using Lean to Cope with Emotions, Thoughts, or Feelings in the Past 30 days” as the dependent variable and the presence of anxiety, depression, and lifetime trauma exposure as independent variables. Age, gender (Reference group [Ref]: Male/Man), and housing status (Ref: I have housing) were added as covariates. The independent variables and covariates were entered simultaneously into the model to examine adjusted odds ratios (AORs). The presence of anxiety, depression, and lifetime trauma exposure were also added separately to examine the unadjusted odds ratios. Anxiety and depression variables were missing 4.4% of data and the lean to cope with emotions in the past 30 days variable was missing <1% of data. Little’s test for Missing Completely at Random (MCAR) revealed that the data were not MCAR (P < .001). Therefore, 5 multiple imputations were conducted to address missingness, and pooled results from all multivariate analyses are described in this paper.
After selecting individuals with a lifetime trauma exposure (n = 524), a second logistic regression model included “lean to cope with emotions, thoughts, or feelings in the past 30 days” as an outcome, the PTSD screen score as an independent variable, and the covariates from the first logistic regression model to examine each variable’s AOR. The PTSD screen was also added separately to examine the unadjusted odds ratio.
Results
Sample characteristics
Table 1 provides sociodemographic, mental health, and lean use characteristics of the full analytical sample (N = 1423). Most participants were employed full-time (n = 964; 67.7%), Male/Men (n = 1102; 77.4%), and have housing (n = 813; 57.1%). The sample had an average age of 26.9 years (SD = 5.2).
Table 1.
Characteristic | n | % | Mean | SD |
---|---|---|---|---|
Sample | 1423 | 100.0 | ||
Age | 26.9 | 5.2 | ||
Employment status | ||||
Disabled or unable to work | 24 | 1.7 | ||
Employed full-time | 964 | 67.7 | ||
Employed part-time | 371 | 26.1 | ||
Unemployed | 32 | 2.2 | ||
Student | 32 | 2.2 | ||
Gender identity | ||||
Male/man | 1102 | 77.4 | ||
Female/woman | 290 | 20.4 | ||
Other gender identity | 31 | 2.2 | ||
Housing status | ||||
I have housing | 813 | 57.1 | ||
Unstable housing | 549 | 38.6 | ||
I do not have housing | 61 | 4.3 | ||
Race and ethnicity | ||||
American Indian or Alaska native | 25 | 1.8 | ||
Black of African American | 145 | 10.2 | ||
Native Hawaiian or Other Pacific Islander | 88 | 6.2 | ||
White | 644 | 45.3 | ||
Hispanic or Latino any race | 437 | 30.7 | ||
Other race and ethnicity | 84 | 5.9 | ||
Sexual identity | ||||
Asexual | 57 | 4.0 | ||
Bisexual | 78 | 5.5 | ||
Gay or lesbian | 58 | 4.1 | ||
Heterosexual or straight | 1211 | 85.1 | ||
Other sexual identity | 19 | 1.3 | ||
Lean ingredients | ||||
Codeine only | 846 | 59.5 | ||
Promethazine only | 244 | 17.1 | ||
Codeine and promethazine | 138 | 9.7 | ||
Other ingredients | 104 | 7.3 | ||
Codeine and other ingredients | 22 | 1.5 | ||
Promethazine and other ingredients | 15 | 1.1 | ||
Codeine, promethazine, and other ingredients | 54 | 3.8 | ||
Past year lean use | ||||
Monthly or less | 617 | 43.4 | ||
2 to 4 times a month | 589 | 41.4 | ||
2 to 3 times per week | 167 | 11.7 | ||
4 or more times a week | 50 | 3.5 | ||
Past 30 d lean use | ||||
No | 127 | 8.9 | ||
Yes | 1296 | 91.1 | ||
Lean use disorder (LUD) a | ||||
Does not meet LUD criteria | 50 | 3.5 | ||
Mild LUD | 71 | 5.0 | ||
Moderate LUD | 185 | 13.0 | ||
Severe LUD | 1117 | 78.5 | ||
Lean to cope with emotions, thoughts, or feelings | ||||
Never | 219 | 15.4 | ||
Yes, ever but not in the past 30 d | 576 | 40.5 | ||
Yes, in the past 30 d | 615 | 43.2 | ||
Missing | 13 | 0.9 | ||
Lean to cope with physical pain | ||||
Never | 272 | 19.1 | ||
Yes, ever | 1138 | 80.0 | ||
Missing | 13 | 0.9 | ||
Lean use disorder identification test b | 4.2 | 1.9 | ||
Lean use disorder a | 6.6 | 2.2 | ||
HADS-anxiety score c | 9.9 | 3.1 | ||
HADS-depression score d | 9.4 | 2.8 | ||
PC-PTSD-5 score e | 4.1 | 1.2 | ||
Anxiety c | 1093 | 76.8 | ||
Depression d | 1112 | 78.1 | ||
Anxiety and depressionc,d | 955 | 67.1 | ||
Lifetime trauma exposure | 524 | 36.8 |
Abbreviation: SD, standard deviation.
Eleven-item measure adapted from the DSM-5-TR. Scores: (a) 0 to 1 no LUD, (b) 2 to 3 mild LUD, (c) 4 to 5 moderate LUD, and (d) ⩾6 severe LUD. Range: 0 to 11.
Three-item measure adapted from the AUDIT-C. Range: 0 to 12.
Hospital anxiety and depression scale: anxiety subscale. Scores: (a) 0 to 7 normal and (b) ⩾8 anxiety. Range: 0 to 21.
Hospital anxiety and depression scale: depression subscale. Scores: (a) 0 to 7 normal and (b) ⩾8 depression. Range: 0 to 21.
Primary care PTSD screen. Range: 0 to 5.
Lean use
Most respondents used lean in the past 30 days (91.1%) and met the screening criteria of having severe lean use disorder (n = 1117; 78.5%). An independent samples t-test identified individuals who met the criteria for a LUD (regardless of severity) (M = 4.2; SD = 1.9) had significantly (P < .05) higher scores than those not meeting the criteria for a LUD (M = 3.4; SD = 2.1) on the LUDIT. Regarding ingredients, most of the sample included codeine as an ingredient in their lean (n = 1060; 74.5%). Less than one-third of the sample (n = 451; 31.7%) added promethazine as an ingredient to their lean.
Anxiety, depression, trauma exposure, and lean to cope
Table 2 shows results of the first logistic regression model. In the adjusted model, anxiety (AOR = 2.36; P < .001; 95% Confidence Interval [CI] = [1.67, 3.34]), lifetime trauma of exposure (AOR = 5.58; P < 001; 95% CI = [4.33, 7.20]), and being Female/Woman (AOR = 1.71; P < 001; 95% CI = [1.27, 2.31]) compared to being Male/Man had increased odds of using lean to cope with emotions, thoughts, or feelings in the past 30 days. However, depression (AOR = 0.47; P < 001; 95% CI = [0.34, 0.66]) and unstable housing (AOR = 0.68; P = .004; 95% CI = [0.52, 0.88]) compared to stable housing had decreased odds of using lean to cope with emotions, thoughts, or feelings in the past 30 days.
Table 2.
Unadjusted | Adjusted | |||||
---|---|---|---|---|---|---|
Unadjusted odds ratio | P-value | 95% Confidence interval | Adjusted odds ratio | P-value | 95% Confidence interval | |
Anxiety (Ref: No) | ||||||
Yes | 2.61*** | <.001 | 1.95, 3.49 | 2.36*** | <.001 | 1.67, 3.34 |
Depression (Ref: No) | ||||||
Yes | 0.67** | .004 | 0.51, 0.88 | 0.47*** | <.001 | 0.34, 0.66 |
Lifetime trauma exposure (Ref: No) | ||||||
Yes | 6.41*** | <.001 | 5.04, 8.16 | 5.58*** | <.001 | 4.33, 7.20 |
Age | 1.02 | .078 | 1.00, 1.05 | |||
Gender (Ref: Male/man) | ||||||
Female/woman | 1.71*** | <.001 | 1.27, 2.31 | |||
Other gender Identity | 1.01 | .977 | 0.45, 2.26 | |||
Housing status (Ref: I have housing) | ||||||
Unstable housing | 0.68** | .004 | 0.52, 0.88 | |||
I do not have housing | 1.20 | .550 | 0.66, 2.21 |
The results are pooled from 5 imputations to address 4.4% of data missing.
Abbreviation: Ref, reference group.
N = 1423.
P < .01. ***P < .001.
PTSD and lean to cope
Table 3 shows the results of the second logistic regression model. In the adjusted model, higher scores on the PTSD severity screener (AOR = 1.90; P < .001; 95% CI = [1.60, 2.26]) had increased odds, and being Female/Woman (AOR = 0.64; P = .048; 95% CI = [0.41, 1.00]) compared to being Male/Man had decreased odds of using lean to cope with emotions, thoughts, or feelings in the past 30 days.
Table 3.
Unadjusted | Adjusted | |||||
---|---|---|---|---|---|---|
Unadjusted odds ratio | P-value | 95% Confidence interval | Adjusted odds ratio | P-value | 95% Confidence interval | |
PTSD severity | 1.85*** | <.001 | 1.56, 2.19 | 1.90*** | <.001 | 1.60, 2.26 |
Age | 1.02 | .306 | 0.99, 1.05 | |||
Gender (Ref: Male/Man) | ||||||
Female/woman | 0.64* | .048 | 0.41, 1.00 | |||
Other gender identity | 0.92 | .874 | 0.34, 2.49 | |||
Housing status (Ref: I have housing) | ||||||
Unstable housing | 0.74 | .173 | 0.48, 1.14 | |||
I do not have housing | 1.11 | .788 | 0.51, 2.44 |
Results are pooled from 5 imputations to address <1% of data missing.
N = 524 individuals with a trauma exposure in their lifetime.
Abbreviation: Ref, reference group.
P < .05. ***P < .001.
Discussion
Although lean is consumed internationally,3,16,20 and has visibility in popular culture,4,9 -12 it remains vastly understudied. This exploratory study focused on gaps in the literature regarding (1) respondent descriptions of lean ingredients, (2) lean use frequency, (3) lean use disorder screening criteria, and (4) persons consuming lean to cope with anxiety, depression, and PTSD symptomology.
Most individuals in this sample reported codeine as the only ingredient (60%) followed by promethazine only (17.1%). The combination of codeine and promethazine was added as ingredients in lean by 13.5% of the sample (n = 192). Regardless of other substances that were added, approximately three-fourths of individuals reported codeine as an ingredient. Although the mixture of codeine and promethazine is the typical description of lean,1 -5 substance availability could affect this. Further, peer, cultural, or geographic norms related to substance use may have an impact on what ingredients must be incorporated to meet the description of lean. One study which captured data from electronic dance music attendees found that 75% of individuals believed their lean ever included codeine as an ingredient and 32% believed it usually or always included codeine as an ingredient. 9 Considering codeine and promethazine are suspected of being diverted by some pharmacists, 3 some persons may only be able to access one ingredient (either codeine or promethazine) and not the other. This current study further specifies the need to identify which ingredients persons self-report as being in their lean.
Most people in our sample drank lean monthly or less, or 2 to 4 times a month. Over three-fourths of the sample met the screening criteria for severe lean use disorder. Considering codeine was the most reported ingredient in lean in this sample, individuals presenting to treatment and meeting the SUD criteria for lean should be screened for the need for opioid withdrawal treatment. 35
Individuals in this sample with greater depression severity had lower odds of using lean to cope in the past 30 days. However, those with greater anxiety or PTSD severity were more likely to use lean to cope with emotions, thoughts, or feelings in the past 30 days. Therefore, treatments for co-occurring mental health and substance use disorder symptomology should be provided simultaneously if individuals are identified as having a mental health symptomology and a SUD. 20
Most of the sample are men, at 77.4%, and young adults with an average age of 27 years old. This is similar to estimates of Reddit users, estimated to be approximately 67% men and 64% of persons ages 18 to 29 years old. 36 Further related to gender, previous studies among college students and electronic dance music party attendees have also identified men as being more likely to have used lean in the past year than women.1,4,8,9 Respondents in this current study are young adults, indicative of Reddit users 31 and the age group expected to consume lean the most.2,3,5 Future studies using non-convenient sampling methods are needed to provide more rigorous findings about lean use, especially the prevalence of lean use.
The purpose of this study was to learn more about the use of lean for screening, ingredient identification, and treatment purposes, not to criminalize or stigmatize substance use or SUDs. 37 Further, these findings are not intended to promote more restrictions on substances (eg, codeine, promethazine) used to treat medical conditions, but to inform protocols for providing support, treatment, and harm-reduction services if a SUD is present or mental health disorder symptoms are identified.
Despite study findings about lean, this study is not without limitations. One limitation is inherent to the data collection methodology of anonymous online surveys. Persons using substance-related subReddits are not representative of all persons using lean. Although Qualtrics’ 23 bot detection (reCAPTCHA) was used, and the chances of receiving an incentive were low, there is still a risk of bots completing the survey or individuals completing the survey multiple times. Another limitation is that 3 of the 10 subReddit moderators that did not respond during the data collection period provided approval afterward and, therefore, these subreddit pages were not part of the recruitment procedures. Another study limitation is the focus on persons ages 18 and older. Future studies may also examine factors related to lean use among youths. No geographic data were captured from respondents, which may have provided context regarding lean mixtures in different regions and countries. Studies are also needed to examine the adaptability, utility, and scoring cut-offs of the LUD and LUDIT (Responses to these measures in this sample may be found in Supplemental Tables 1 and 2), both of which are unvalidated measures. Another limitation is the Cronbach alphas are lower than ideal in this exploratory study. The use of probability sampling methods in future studies about lean use is also warranted to represent the population.
Supplemental Material
Supplemental material, sj-doc-1-sat-10.1177_11782218231195226 for Lean/Sizzurp Ingredients, Use, and Coping With Mental Health Symptoms by Orrin D Ware in Substance Abuse: Research and Treatment
Acknowledgments
Dr. Jordan Wingate, I thank you for your thoughtful edits. Hannah Neukrug, thank you for your keen eye when pilot-testing the survey. To the Moderators of Reddit, I express my immense gratitude for allowing me to post the study recruitment material. I also express my gratitude to the persons who completed this survey; without your participation, this study would be impossible.
Footnotes
Author Contributions: The author Orrin D. Ware confirms sole responsibility for completing all aspects of the study.
Funding: The author received no external financial support for the research, authorship, and/or publication of this article.
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Supplemental Material: Supplemental material for this article is available online.
References
- 1. Agnich LE, Stogner JM, Miller BL, Marcum CD. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict Behav. 2013;38:2445-2449. [DOI] [PubMed] [Google Scholar]
- 2. Garcin L, Le Roch M, Agbessi CA, Lobut JB, Lecoeur A, Benoist G. Purple drank: a dangerous cocktail. Arch Pediatr. 2016;23:1165-1168. [DOI] [PubMed] [Google Scholar]
- 3. Jouanjus E, Falcou A, Deheul S, Roussin A, Lapeyre-Mestre M. Detecting the diverted use of psychoactive drugs by adolescents and young adults: a pilot study. Pharmacoepidemiol Drug Saf. 2018;27:1286-1292. [DOI] [PubMed] [Google Scholar]
- 4. Miuli A, Stigliano G, Lalli A, et al. “Purple drank” (codeine and promethazine cough syrup): a systematic review of a social phenomenon with medical implications. J Psychoactive Drugs. 2020;52:453-462. [DOI] [PubMed] [Google Scholar]
- 5. Rosenberger W, Teske J, Klintschar M, Dziadosz M. Detection of pharmaceuticals in “dirty sprite” using gas chromatography and mass spectrometry. Drug Test Anal. 2022;14:539-544. [DOI] [PubMed] [Google Scholar]
- 6. Weintraub M, Moscucci M. Taste preference for cough syrups: a comparative study of three codeine-containing medications. Clin Ther. 1986;8:348-353. [PubMed] [Google Scholar]
- 7. Cherian R, Westbrook M, Ramo D, Sarkar U. Representations of codeine misuse on Instagram: content analysis. JMIR Public Health Surveill. 2018;4:e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hart M, Agnich LE, Stogner J, Miller BL. ‘Me and my drank:’ exploring the relationship between musical preferences and purple drank experimentation. Am J Crim Justice. 2014;39:172-186. [Google Scholar]
- 9. Palamar JJ. Use of “lean” among electronic dance music party attendees. Am J Addict. 2019;28:347-352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Peters RJ, Kelder SH, Markham CM, Yacoubian GS, Peters LA, Ellis A. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among urban Houstonian adolescents: an addiction trend in the city of lean. J Drug Educ. 2003;33:415-425. [DOI] [PubMed] [Google Scholar]
- 11. Tettey N-S, Siddiqui K, Llamoca H, Nagamine S, Ahn S. Purple drank, sizurp, and lean: hip-hop music and codeine use: a call to action for public health educators. Int J Psychol Stud. 2020;12:42-52. [Google Scholar]
- 12. Peteet B, Roundtree C, Dixon S, et al. ‘Codeine crazy:’ a content analysis of prescription drug references in popular music. J Youth Stud. 2021;24: 1100-1116. [Google Scholar]
- 13. Chiappini S, Schifano F, Corkery JM, Guirguis A. Beyond the ‘purple drank’: study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. J Psychopharmacol. 2021;35:681-692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Chiappini S, Schifano F. What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs. Brain Sci. 2020;10:736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Peters R, Yacoubian GS, Rhodes W, et al. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. J Psychoactive Drugs. 2007;39:277-282. [DOI] [PubMed] [Google Scholar]
- 16. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013;4:75-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Schifano F, Chiappini S, Miuli A, et al. Focus on over-the-counter drugs’ misuse: a systematic review on antihistamines, cough medicines, and decongestants. Front Psychiatry. 2021;12:657397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Elwood WN. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J Psychoactive Drugs. 2001;33:121-133. [DOI] [PubMed] [Google Scholar]
- 19. Reilly O, Thomas D, Moylett M, E, Cough, codeine and confusion. BMJ Case Rep. 2015;2015:bcr2015212727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Ahmed H. Recognising post-traumatic stress disorder in cough syrup misuse. Lancet Psychiatry. 2020;7:737-738. [DOI] [PubMed] [Google Scholar]
- 21. Thornton LK, Baker AL, Lewin TJ, et al. Reasons for substance use among people with mental disorders. Addict Behav. 2012;37:427-434. [DOI] [PubMed] [Google Scholar]
- 22. Votaw VR, Witkiewitz K. Motives for substance use in daily life: a systematic review of studies using ecological momentary assessment. Clin Psychol Sci. 2021;9:535-562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Qualtrics. Provo, UT. 2023. [Google Scholar]
- 24. Billioux A, Verlander K, Anthony S, Alley D. Standardized screening for health-related social needs in clinical settings: The accountable health communities screening tool. National Academy of Medicine Perspectives. 2017. DOI: 10.31478/201705b [DOI] [Google Scholar]
- 25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370. [DOI] [PubMed] [Google Scholar]
- 26. Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Palacios-Ceña M, et al. Psychometric properties of the hospital anxiety and depression scale (HADS) in previously hospitalized COVID-19 patients. Int J Environ Res Public Health. 2022;19:9273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Huang XJ, Ma HY, Wang XM, Zhong J, Sheng DF, Xu MZ. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder. J Affect Disord. 2022;311:327-335. [DOI] [PubMed] [Google Scholar]
- 28. Luckett T, Butow PN, King MT, et al. A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer. 2010;18:1241-1262. [DOI] [PubMed] [Google Scholar]
- 29. Meades R, Ayers S. Anxiety measures validated in perinatal populations: a systematic review. J Affect Disord. 2011;133:1-15. [DOI] [PubMed] [Google Scholar]
- 30. Sardella A, Musetti A, Caponnetto P, Quattropani MC, Lenzo V. Prolonged grief disorder and symptoms of anxiety and depression among bereaved family caregivers in the context of palliative home care. Eur J Investig Health Psychol Educ. 2023;13:490-500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Prins A, Bovin MJ, Smolenski DJ, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31:1206-1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158:1789-1795. [DOI] [PubMed] [Google Scholar]
- 33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th text rev ed. American Psychiatric Association; 2022. [Google Scholar]
- 34. IBM Corp. IBM SPSS Statistics: Version 28.0. 2021.
- 35. Shah M, Huecker MR. Opioid Withdrawal. StatPearls Publishing; 2023. Accessed July 25, 2023. https://www.ncbi.nlm.nih.gov/books/NBK526012/ [PubMed] [Google Scholar]
- 36. Barthel M, Stocking J, Holcomb J, Mitchell A. 1. Reddit news users more likely to be male, young and digital in their news preferences. 2016. Accessed July 25, 2023. https://www.pewresearch.org/journalism/2016/02/25/reddit-news-users-more-likely-to-be-male-young-and-digital-in-their-news-preferences/
- 37. Miller BL, Stogner JM, Agnich LE, Sanders A, Bacot J, Felix S. Psychoactive drugs (NPDs) and its relationship with legal changes. Am J Crim Justice. 2015;40:523-541. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material, sj-doc-1-sat-10.1177_11782218231195226 for Lean/Sizzurp Ingredients, Use, and Coping With Mental Health Symptoms by Orrin D Ware in Substance Abuse: Research and Treatment